European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading

MT Newswires Live05-11 23:05

European equities traded in the US as American depositary receipts opened the week on a flat note Monday morning, edging 0.08% higher to 1,835.34 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company Cellectis (CLLS), which advanced 8.1% and 6.3% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and telecommunications company Ericsson (ERIC), which increased 4.9% and 3.2% respectively.

The decliners from continental Europe were led by consumer goods company Unilever (UL) and biopharmaceutical company Grifols (GRFS), which fell 1.9% and 1.3% respectively. They were followed by internet browser company Opera (OPRA) and accommodations booking site trivago (TRVG), which were down 1% each.

The gainers from the UK were led by cruise line operator Carnival (CUK) and pharmaceutical company Silence Therapeutics (SLN), which rose 6.6% and 4.7% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Amarin (AMRN), which were up 3.9% and 3.4% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Mereo BioPharma Group (MREO), which lost 10% and 7.3% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and software firm Endava (DAVA), which dropped 5.8% and 2.2% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment